3 years ago
FATE
AnalystsRobert BurnsRobert Burns's Stock Forecasts
AnalystsRobert Burns
Sectors:
Industries:
Analyst Ranking
Bottom 4%
#4944 out of 5115 analysts
Average Return
-1.14%
Win Rate
39%208 out of 538
Risk vs Reward
Poor
Good
Robert Burns's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Tango Therapeutics IncTNGX | +702.99% | $1.34 | $10.76 | 2025-04-14 - 2025-11-26 | Buy |
Cogent Biosciences IncCOGT | +660.64% | $5.31 | $40.39 | 2025-05-20 - 2025-11-26 | Buy |
Cogent Biosciences IncCOGT | +448.03% | $7.37 | $40.39 | 2025-01-14 - 2025-11-26 | Buy |
Immunomedics IncIMMU | +342.36% | $18.91 | $83.65 | 2020-04-07 - 2020-09-14 | Buy |
Nuvation Bio IncNUVB | +326.06% | $1.88 | $8.01 | 2025-03-10 - 2025-11-26 | Buy |
Robert Burns Analyst Color
Get additional color on Robert Burns's coverage of popular stocks
Robert Burns's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cullinan Therapeutics IncCGEM | 3 | Buy | $26.00 | +121.47% | Maintains | 7 days ago |
Zymeworks IncZYME | 23 | Buy | $32.00 | +17.09% | Maintains | 9 days ago |
Oric Pharmaceuticals IncORIC | 26 | Buy | $23.00 | +94.59% | Maintains | 13 days ago |
Cogent Biosciences IncCOGT | 14 | Buy | $50.00 | +23.79% | Maintains | 14 days ago |
Biontech SeBNTX | 44 | Buy | $140.00 | +36.32% | Maintains | 17 days ago |
Adicet Bio IncACET | 2 | Buy | $9.00 | +1,397.50% | Maintains | 20 days ago |
Revolution Medicines IncRVMD | 19 | Buy | $73.00 | -5.90% | Maintains | 21 days ago |
Exelixis IncEXEL | 11 | Buy | $49.00 | +10.83% | Maintains | 22 days ago |
Caribou Biosciences IncCRBU | 15 | Buy | $9.00 | +378.72% | Maintains | 22 days ago |
Macrogenics IncMGNX | 19 | Hold | $2.00 | +35.14% | Reiterates | 24 days ago |
Fate Therapeutics IncFATE | 7 | Buy | $5.00 | +354.55% | Upgrades | a month ago |
Repare Therapeutics IncRPTX | 19 | Buy | $3.00 | +35.75% | Maintains | a month ago |
Nurix Therapeutics IncNRIX | 19 | Buy | $28.00 | +62.79% | Maintains | a month ago |
Replimune Group IncREPL | 17 | Buy | $12.00 | +19.28% | Upgrades | a month ago |
Bolt Biotherapeutics IncBOLT | 1 | Buy | $7.00 | +41.41% | Assumes | a month ago |
Adc Therapeutics SaADCT | 19 | Buy | $7.00 | +61.66% | Maintains | a month ago |
Karyopharm Therapeutics IncKPTI | 2 | Buy | $15.00 | +170.27% | Upgrades | a month ago |
Perspective Therapeutics IncCATX | 5 | Buy | $10.00 | +348.43% | Reiterates | 2 months ago |
Prelude Therapeutics IncPRLD | 17 | Buy | $5.00 | +199.40% | Reiterates | 2 months ago |
Nuvation Bio IncNUVB | 15 | Buy | $10.00 | +24.84% | Reiterates | 2 months ago |
Bridgebio Oncology Therapeutics IncBBOT | 1 | Buy | $27.00 | +121.67% | Initiates Coverage On | 2 months ago |
IMMIX Biopharma IncIMMX | 9 | Buy | $8.00 | +86.05% | Maintains | 2 months ago |
Telix Pharmaceuticals LtdTLX | 2 | Buy | $20.00 | +105.13% | Maintains | 3 months ago |
Onkure Therapeutics IncOKUR | 4 | Buy | $34.00 | +1,088.81% | Reiterates | 3 months ago |
Relay Therapeutics IncRLAY | 21 | Buy | $14.00 | +74.35% | Maintains | 3 months ago |
Bicara Therapeutics IncBCAX | 5 | Buy | $40.00 | +110.53% | Maintains | 3 months ago |
Arrivent Biopharma IncAVBP | 11 | Buy | $42.00 | +82.21% | Maintains | 3 months ago |
Black Diamond Therapeutics IncBDTX | 14 | Buy | $10.00 | +164.55% | Maintains | 4 months ago |
Y Mabs Therapeutics IncYMAB | 15 | Hold | $8.60 | -0.12% | Downgrades | 4 months ago |
Cardiff Oncology IncCRDF | 3 | Buy | $10.00 | +327.35% | Maintains | 4 months ago |
Elicio Therapeutics IncELTX | 8 | Buy | $13.00 | +41.92% | Maintains | 4 months ago |
Enliven Therapeutics IncELVN | 5 | Buy | $48.00 | +121.10% | Maintains | 5 months ago |
Tuhura Biosciences IncHURA | 3 | Buy | $12.00 | +474.16% | Reiterates | 6 months ago |
Springworks Therapeutics IncSWTX | 29 | Hold | $47.00 | +0.02% | Downgrades | 7 months ago |
Tango Therapeutics IncTNGX | 12 | Buy | $13.00 | +20.82% | Reiterates | 7 months ago |
Pmv Pharmaceuticals IncPMVP | 11 | Buy | $5.00 | +273.13% | Reiterates | 8 months ago |
Allogene Therapeutics IncALLO | 14 | Buy | $8.00 | +463.38% | Maintains | 8 months ago |
Cargo Therapeutics IncCRGX | 3 | Buy | $33.00 | N/A | Reiterates | a year ago |
Igm Biosciences IncIGMS | 13 | Hold | $11.00 | N/A | Maintains | a year ago |
Kronos Bio IncKRON | 10 | Buy | $2.25 | N/A | Reiterates | a year ago |
Omega Therapeutics IncOMGAQ | 9 | Buy | $12.00 | N/A | Reiterates | a year ago |
Apollomics IncAPLM | 5 | Buy | $200.00 | N/A | Maintains | 2 years ago |
Viracta Therapeutics IncVIRX | 8 | Buy | $4.00 | N/A | Reiterates | 2 years ago |
Effector Therapeutics IncEFTR | 3 | Buy | $24.00 | N/A | Reiterates | 2 years ago |
Calidi Biotherapeutics IncCLDI | 2 | Buy | $240.00 | N/A | Maintains | 2 years ago |
Kineta IncKANT | 4 | Buy | $8.00 | N/A | Reiterates | 2 years ago |
Alphaton Capital CorpATON | 5 | Buy | $120.00 | N/A | Maintains | 2 years ago |
Whitehawk Therapeutics IncWHWK | 9 | Buy | $36.00 | N/A | Maintains | 2 years ago |
Kinnate Biopharma IncKNTE | 6 | Buy | $24.00 | N/A | Reiterates | 2 years ago |
Gt Biopharma IncGTBP | 6 | Buy | $150.00 | N/A | Reiterates | 2 years ago |
Atara Biotherapeutics IncATRA | 8 | Buy | $700.00 | N/A | Maintains | 2 years ago |
Imagenebio IncIMA | 4 | Buy | $264.00 | N/A | Reiterates | 3 years ago |
Tcr2 Therapeutics IncTCRR | 4 | Buy | $13.00 | N/A | Maintains | 3 years ago |
Neurogene IncNGNE | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Forma Therapeutics Holdings IncFMTX | 2 | Hold | $20.00 | N/A | Downgrades | 3 years ago |
Turning Point Therapeutics IncTPTX | 6 | Hold | $76.00 | N/A | Downgrades | 3 years ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $11.00 | N/A | Maintains | 4 years ago |
Nucana PLCNCNA | 7 | Buy | $45,000.00 | N/A | Maintains | 4 years ago |
Molecular Partners AgMOLN | 1 | Buy | $25.00 | N/A | Assumes | 4 years ago |
Autolus Therapeutics PLCAUTL | 1 | Buy | $13.00 | N/A | Maintains | 5 years ago |
Immunomedics IncIMMU | 4 | Hold | $88.00 | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.